Identifying potential repurposable medications for Parkinson's disease through Mendelian randomization analysis

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• Observational studies suggest medication benefits for Parkinson's disease (PD), but findings are inconsistent.
• The potential for drug repurposing in PD requires robust causal evidence.
• Investigating genetic associations can clarify medication effects on PD risk and progression.

Purpose of the Study:

• To explore causal relationships between 23 medications and Parkinson's disease (PD) risk and progression.
• To address inconsistencies in observational study findings using genetic methods.
• To identify potential drug candidates for PD treatment or prevention.

Main Methods:

• Two-sample Mendelian randomization (MR) analysis was employed.
• Inverse-variance weighted (IVW) meta-analysis combined MR estimates.
• Sensitivity analyses were performed to ensure result robustness.

Main Results:

• Genetic evidence suggests thyroid preparations and calcium channel blockers may reduce PD risk.
• Salicylic acid and derivatives show potential for slowing PD motor symptom progression.
• While some associations were found, sensitivity analyses indicated potential reverse causality for three medications.

Conclusions:

• Weak causal relationships exist between certain medications and PD risk or progression.
• Findings offer new insights into PD etiology and potential drug discovery avenues.
• Further replication studies are essential to validate these genetic associations.